Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -435.83% is 39% above its 5-year average of -717.46%, near the high end of its 5-year range (-50800.00%–7.22%).
18.10% above its 12-month average of -532.15%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1943.21%.
NET PROFIT MARGIN
-435.83%
NET PROFIT MARGIN AVG TTM
-532.15%
NET PROFIT MARGIN AVG 3Y
-445.21%
NET PROFIT MARGIN AVG 5Y
-717.46%
NET PROFIT MARGIN AVG 10Y
-952.94%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+18.10%
CURRENT VS 3Y AVG
+2.11%
CURRENT VS 5Y AVG
+39.25%
CURRENT VS 10Y AVG
+54.26%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 563 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cue Biopharma, Inc.
Market Cap
$176.13M
Net Profit Margin
-435.83%
TTM Avg
-532.15%
3Y Avg
-445.21%
5Y Avg
-717.46%
Market Cap
$178.23M
Net Profit Margin
-6559.27%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$173.51M
Net Profit Margin
0.00%
TTM Avg
-2904.41%
3Y Avg
-1452.20%
5Y Avg
-968.14%
Market Cap
$181.64M
Net Profit Margin
-8.95%
TTM Avg
-22.31%
3Y Avg
-22.43%
5Y Avg
-24.59%
Market Cap
$172.62M
Net Profit Margin
-117.04%
TTM Avg
-61.51%
3Y Avg
-173.42%
5Y Avg
-194.84%
Market Cap
$172.45M
Net Profit Margin
-170.10%
TTM Avg
-145.13%
3Y Avg
-100.04%
5Y Avg
-83.24%
Market Cap
$191.07M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$162.23M
Net Profit Margin
-257.10%
TTM Avg
-196.56%
3Y Avg
-155.96%
5Y Avg
-114.00%
Market Cap
$192.58M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | $176.13M | -435.83% | -532.15% | -445.21% | -717.46% |
| Canton Strategic Holdings Inc (CNTN)vs › | $178.23M | -6559.27% | 0.00% | 0.00% | 0.00% |
| Compass Therapeutics, Inc. (CMPX)vs › | $173.51M | 0.00% | -2904.41% | -1452.20% | -968.14% |
| Journey Medical Corporation (DERM)vs › | $181.64M | -8.95% | -22.31% | -22.43% | -24.59% |
| Precision BioSciences, Inc. (DTIL)vs › | $172.62M | -117.04% | -61.51% | -173.42% | -194.84% |
| MediWound Ltd. (MDWD)vs › | $172.45M | -170.10% | -145.13% | -100.04% | -83.24% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $191.07M | 0.00% | 0.00% | 0.00% | 0.00% |
| Coherus Oncology, Inc. (CHRS)vs › | $162.23M | -257.10% | -196.56% | -155.96% | -114.00% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $192.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| Inogen, Inc. (INGN)vs › | $159.88M | -6.94% | -8.61% | -17.97% | -12.59% |
Operating Margin
-96.6%
Net Profit Margin
-435.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1943.21% |
| 2026-03-31 | -91.07% |
| 2025-12-31 | 7.22% |
| 2025-09-30 | -346.58% |
| 2025-06-30 | -287.14% |
| 2025-03-31 | -2911.40% |
| 2024-12-31 | -602.54% |
| 2024-09-30 | -259.59% |
| 2024-06-30 | -382.66% |
| 2024-03-31 | -719.10% |
| 2023-12-31 | -737.73% |
| 2023-09-30 | -524.05% |
| 2023-06-30 | -954.05% |
| 2023-03-31 | -7010.16% |
| 2022-12-31 | -9663.58% |
| 2022-09-30 | -16110.29% |
| 2022-06-30 | -50800.00% |
| 2022-03-31 | -1425.50% |
| 2021-12-31 | -101.57% |
| 2021-09-30 | -542.51% |
| 2021-06-30 | -375.28% |
| 2021-03-31 | -805.22% |
| 2020-12-31 | -2335.86% |
| 2020-09-30 | -1424.86% |
| 2020-06-30 | -1007.72% |
| 2020-03-31 | -1424.22% |
| 2019-12-31 | -849.78% |
| 2019-09-30 | -710.37% |
| 2019-06-30 | -902.56% |
| 2019-03-31 | -3045.14% |
| 2018-12-31 | -3515.18% |
| 2018-09-30 | -2797.10% |
| 2018-06-30 | -4244.19% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
